Follow
Leo Serebryannyy
Leo Serebryannyy
NIAID
Verified email at nih.gov
Title
Cited by
Cited by
Year
Nuclear actin and myosins: life without filaments
P De Lanerolle, L Serebryannyy
Nature cell biology 13 (11), 1282-1288, 2011
1662011
Persistent nuclear actin filaments inhibit transcription by RNA polymerase II
LA Serebryannyy, M Parilla, P Annibale, CM Cruz, K Laster, E Gratton, ...
Journal of cell science 129 (18), 3412-3425, 2016
802016
A role for nuclear actin in HDAC 1 and 2 regulation
LA Serebryannyy, CM Cruz, P de Lanerolle
Scientific reports 6 (1), 28460, 2016
782016
Low-dose subcutaneous or intravenous monoclonal antibody to prevent malaria
RL Wu, AH Idris, NM Berkowitz, M Happe, MR Gaudinski, C Buettner, ...
New England Journal of Medicine 387 (5), 397-407, 2022
672022
α-Catenin is an inhibitor of transcription
RL Daugherty, L Serebryannyy, A Yemelyanov, AS Flozak, HJ Yu, ...
Proceedings of the National Academy of Sciences 111 (14), 5260-5265, 2014
632014
Immune correlates analysis of the ENSEMBLE single Ad26. COV2. S dose vaccine efficacy clinical trial
Y Fong, AB McDermott, D Benkeser, S Roels, DJ Stieh, A Vandebosch, ...
Nature microbiology 7 (12), 1996-2010, 2022
562022
Protein sequestration at the nuclear periphery as a potential regulatory mechanism in premature aging
L Serebryannyy, T Misteli
Journal of Cell Biology 217 (1), 21-37, 2018
412018
Safety and efficacy of a monoclonal antibody against malaria in Mali
K Kayentao, A Ongoiba, AC Preston, SA Healy, S Doumbo, D Doumtabe, ...
New England Journal of Medicine 387 (20), 1833-1842, 2022
382022
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses
CM Buckner, L Kardava, O El Merhebi, SR Narpala, L Serebryannyy, ...
Cell 185 (23), 4333-4346. e14, 2022
362022
The modified-bead stretched sample method: development and application to MALDI-MS imaging of protein localization in the spinal cord
KR Tucker, LA Serebryannyy, TA Zimmerman, SS Rubakhin, JV Sweedler
Chemical science 2 (4), 785-795, 2011
322011
The effects of disease models of nuclear actin polymerization on the nucleus
LA Serebryannyy, M Yuen, M Parilla, ST Cooper, P De Lanerolle
Frontiers in Physiology 7, 454, 2016
292016
Blank spots on the map: some current questions on nuclear organization and genome architecture
C Adriaens, LA Serebryannyy, M Feric, A Schibler, KJ Meaburn, ...
Histochemistry and Cell Biology 150, 579-592, 2018
272018
Nuclear α-catenin mediates the DNA damage response via β-catenin and nuclear actin
LA Serebryannyy, A Yemelyanov, CJ Gottardi, P de Lanerolle
Journal of cell science 130 (10), 1717-1729, 2017
262017
Nuclear actin and myosins in adenovirus infection
B Fuchsova, LA Serebryannyy, P De Lanerolle
Experimental cell research 338 (2), 170-182, 2015
262015
Nuclear actin: The new normal
L Serebryannyy, P de Lanerolle
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 821 …, 2020
222020
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults
AT Widge, AR Hofstetter, KV Houser, SF Awan, GL Chen, ...
Science translational medicine 15 (692), eade4790, 2023
192023
Stretched tissue mounting for MALDI mass spectrometry imaging
KR Tucker, EJ Lanni, LA Serebryannyy, SS Rubakhin, JV Sweedler
Analytical chemistry 83 (23), 9181-9185, 2011
162011
Tumor stiffness is unrelated to myosin light chain phosphorylation in cancer cells
HJ Yu, LA Serebryannyy, M Fry, M Greene, O Chernaya, WY Hu, TL Chew, ...
PLoS One 8 (11), e79776, 2013
142013
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
KE Lyke, RL Atmar, C Dominguez Islas, CM Posavad, ME Deming, ...
npj Vaccines 8 (1), 98, 2023
132023
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial
KE Lyke, AA Berry, K Mason, AH Idris, M O'Callahan, M Happe, L Strom, ...
The Lancet Infectious Diseases 23 (5), 578-588, 2023
132023
The system can't perform the operation now. Try again later.
Articles 1–20